Aevion Ventures is a biotech-focused venture firm partnering with scientists, founders, and leading institutions to translate cutting-edge research into meaningful healthcare solutions. We work hands-on with our portfolio companies to bridge the gap between scientific discovery and commercial success.

At Aevion Ventures, we invest in breakthrough life science innovations with the potential to improve the lives of millions worldwide. Our focus is on advancing transformative technologies from discovery through clinical development and into real-world application.

The Canadian biotech market presents a compelling opportunity for generating strong returns while building companies with global impact. Despite world-class research and talent, Canadian biotech remains underfunded, creating a favorable investment environment with access to exceptional assets at attractive valuations.

This moment is particularly opportune for biotech investment, driven by urgent global healthcare needs, aging populations, and increasing strain on healthcare systems worldwide.

Led by Managing Partners with extensive venture-building experience and former senior executives from global pharmaceutical companies, Aevion Ventures brings deep expertise across drug development, clinical strategy, and commercialization. We are entrepreneurs and scientists who have navigated these challenges firsthand.

Our approach combines scientific rigor, strategic insight, and a long-term vision to build and support high-impact biotech ventures that deliver both strong returns and lasting clinical impact.